Drug Discovery and Development

  • Home Drug Discovery and Development
  • Drug Discovery
  • Women in Pharma and Biotech
  • Oncology
  • Neurological Disease
  • Infectious Disease
  • Resources
    • Video features
    • Podcast
    • Voices
    • Views
    • Webinars
  • Pharma 50
    • 2025 Pharma 50
    • 2024 Pharma 50
    • 2023 Pharma 50
    • 2022 Pharma 50
    • 2021 Pharma 50
  • Advertise
  • SUBSCRIBE

Diabetes and Buildup of Tau May Be Linked

By Drug Discovery Trends Editor | September 4, 2015

People with type 2 diabetes may have a greater buildup of tangles of protein in their spinal fluid, irrespective of dementia, according to a new study published Sept. 2 in Neurology.

The study, led by researchers at Monash University in Melbourne, Australia, looked at the relationship between type 2 diabetes, the levels of beta amyloid and tau protein in the spinal fluid, and the loss of brain cells and their connection. 

Of the 816 participants involved, 124 had diabetes, 397 had mild cognitive impairment, 191 had Alzheimer’s disease and 228 had no memory and thinking problems.  The average age of participants was 74.

Participants with diabetes, on average, had 16 picograms per milliliter greater levels of the tau protein in the spinal and brain fluid, regardless of whether or not they had dementia, which may reflect a greater buildup of tangles in the brain.

“Evidence shows that people with type 2 diabetes have double the risk of developing dementia,” said author Velandai Srikanth, M.D., Ph.D. “This interesting development further defines how the diseases may be connected.”

The accumulation of tangles may also contribute to the loss of brain tissue, and according to the study, diabetes was associated with an average of 0.03 millimeter less cortical tissue in brains of participants who had diabetes than those who did not.

“Due to the fact that nerve cells in the brain do not replace themselves, it is extremely important to find ways to reduce the death of current brain cells.  Studies such as ours seek to understand how diseases like diabetes may directly or indirectly affect brain cell death,” Srikanth said. 

The study did not determine a cause-and-effect relationship between diabetes and brain tangles.


Filed Under: Drug Discovery

 

Related Articles Read More >

The FDA’s AI ambitions depend on better data practices
Researchers working in the clinical laboratory
Outpatient clinics are becoming critical Infrastructure for drug trials
SAS launches clinical trial analytics software built on its Viya cloud native analytics platform
Bayer’s Lynkuet approved by FDA for menopausal hot flashes
“ddd
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest news and trends happening now in the drug discovery and development industry.

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Drug Discovery and Development
  • MassDevice
  • DeviceTalks
  • Medtech100 Index
  • Medical Design Sourcing
  • Medical Design & Outsourcing
  • Medical Tubing + Extrusion
  • Subscribe to our E-Newsletter
  • Contact Us
  • About Us
  • R&D World
  • Drug Delivery Business News
  • Pharmaceutical Processing World

Copyright © 2025 WTWH Media LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media
Privacy Policy | Advertising | About Us

Search Drug Discovery & Development

  • Home Drug Discovery and Development
  • Drug Discovery
  • Women in Pharma and Biotech
  • Oncology
  • Neurological Disease
  • Infectious Disease
  • Resources
    • Video features
    • Podcast
    • Voices
    • Views
    • Webinars
  • Pharma 50
    • 2025 Pharma 50
    • 2024 Pharma 50
    • 2023 Pharma 50
    • 2022 Pharma 50
    • 2021 Pharma 50
  • Advertise
  • SUBSCRIBE